Friday, August 8, 2025

MobiKwik shares fall further from IPO price after a 13% drop; Here’s why

Date:

Shares of One MobiKwik Systems Ltd., parent company of payment solutions provider MobiKwik, fell as much as 13% on Monday, March 17, after its shareholder lock-in ended.As many as 46 lakh shares or 6% of MobiKwik’s outstanding equity became eligible to be traded on Monday after its three-month shareholder lock-in period came to an end, according to data from Nuvama Alternative and Quantitative Research.

With this fall, MobiKwik’s

shares have slipped further below their IPO price of ₹279 per share. The stock fell below that level in the week gone by.
For the December quarter, MobiKwik’s revenue increased by 17.7% from last year to ₹269.5 crore, while its total income also increased by 18.6% year-on-year to ₹274.5 crore.MobiKwik reported a net loss of ₹55.3 crore during the quarter, compared to a ₹5.3 crore profit last year and a loss of ₹3.6 crore in the previous quarter.

MobiKwik is tracked only by one analyst, Dolat Capital Markets, who has a “buy” rating on the stock with a price target of ₹700 per share.

Shares of One MobiKwik are trading 7% lower, having recovered from the day’s low at ₹251.85. The stock is down 65% from its post-listing high of ₹698.

Also Read: Shareholder Lock-In: From Vishal Mega Mart to MobiKwik, these stocks are on the radar today

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Bonds prices under pressure ahead of ₹25,000 crore auction of government securities

सरकारी बॉन्ड शुक्रवार को शुरुआती कारोबार में डूबा, क्योंकि...

Anup Engineering Q1 results | Revenue surges 20% year-on-year to ₹175 crore

Gujarat-based Anup Engineering, a manufacturer of critical process equipment...

Samir Arora sees modest returns ahead, no quick RBI rate cut likely

Samir Arora, Founder and Fund Manager at Helios Capital,...

Advances in breast cancer treatments bring in a range of benefits for patients – The Hindu

Advances in breast cancer treatments bring in a range...